Cargando…
Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection
BACKGROUND: Several anti-retroviral drugs are available against Human immunodeficiency virus type-1, but have multiple adverse side effects. Hence, there is an incessant compulsion for effectual anti-retroviral agents with minimal or no intricacy. Traditionally, natural products have been the most s...
Autores principales: | Jadaun, Pratiksha, Harshithkumar, R, Gaikwad, Shraddha Y, Seniya, Chandrabhan, Borse, Swapnil, Gawai, Ashish A, Chavan-Gautam, Preeti, Tillu, Girish, Mukherjee, Anupam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401819/ https://www.ncbi.nlm.nih.gov/pubmed/37537596 http://dx.doi.org/10.1186/s12985-023-02130-y |
Ejemplares similares
-
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
por: Saggam, Akash, et al.
Publicado: (2021) -
Elucidation of Antiviral and Antioxidant Potential of C-Phycocyanin against HIV-1 Infection through In Silico and In Vitro Approaches
por: Jadaun, Pratiksha, et al.
Publicado: (2022) -
Withania Coagulans and Somnifera
por: Verghese, M.
Publicado: (1885) -
In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
por: Kasarla, Siva Swapna, et al.
Publicado: (2022) -
Withania somnifera as a potential future drug molecule for COVID-19
por: Kashyap, Vivek K, et al.
Publicado: (2020)